Comprehensive Tumor Panel 320 Genes Test
Also known as: Tumor Panel 320, Cancer Gene Panel 320, Comprehensive Cancer Panel
Comprehensive Tumor Panel 320 Genes Test test available at DNA Labs India for ₹33,000. Uses Next Generation Sequencing (NGS) on FFPE Tissue Block, Tissue samples. Results in Results are typically available within 21 working days after the laboratory receives the sample.. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr Pasupathy Arumugam
Consultant Pathologist · Reg: 21521
Last reviewed: September 7, 2026
Overview
The purpose of the Comprehensive Tumor Panel 320 Genes test is to identify genetic alterations in tumor DNA that can inform cancer diagnosis, prognosis, and treatment. It helps in detecting somatic mutations that may be targeted by FDA-approved drugs or investigational agents, thus enabling precision oncology. The panel also aids in identifying hereditary cancer syndromes when germline testing is indicated, and can guide clinical trial enrollment. By providing a comprehensive mutational profile, the test assists oncologists in making evidence-based decisions regarding chemotherapy, targeted therapy, immunotherapy, and monitoring of minimal residual disease.
- Test Code
- 6285
- CPT Code
- 81479
- ICD Code
- Z12.9
- Price
- ₹33,000
- Sample Type
- FFPE Tissue Block, Tissue
- Result Time
- Results are typically available within 21 working days after the laboratory receives the sample.
- Fasting Required
- No
- Method
- Next Generation Sequencing (NGS)
Sample Collection
No special preparation is required. However, the patient should inform the doctor about any medications or supplements they are taking.
Method: Biopsy or surgical specimen
Laboratory Analysis
The sample is collected via biopsy or surgical excision. The tissue is placed in a sterile container with formalin or as a paraffin block.
Report Delivery
The sample is sent to the laboratory for processing. The patient can resume normal activities immediately.
Timeline: Results are typically available within 21 working days after the laboratory receives the sample.
Patient Instructions
About This Test
Who Should Get This Test
The purpose of the Comprehensive Tumor Panel 320 Genes test is to identify genetic alterations in tumor DNA that can inform cancer diagnosis, prognosis, and treatment. It helps in detecting somatic mutations that may be targeted by FDA-approved drugs or investigational agents, thus enabling precision oncology. The panel also aids in identifying hereditary cancer syndromes when germline testing is indicated, and can guide clinical trial enrollment. By providing a comprehensive mutational profile, the test assists oncologists in making evidence-based decisions regarding chemotherapy, targeted therapy, immunotherapy, and monitoring of minimal residual disease.
How to Prepare
- Ensure the tissue sample is obtained from a tumor site.
- The specimen should be fixed in 10% neutral buffered formalin for at least 6 hours but not more than 48 hours.
- For FFPE blocks, ensure adequate tumor content (at least 20% tumor cells).
- Label the specimen with patient identification and collection date.
Doctor's Notes
Reviewed by Dr Pasupathy Arumugam — MBBS, MD (Pathology) · Reg. No. 21521
"This comprehensive panel is crucial for identifying actionable mutations in solid tumors, enabling personalized treatment strategies and improving patient outcomes."
Last medically reviewed: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Inadequate tissue sample
- Sample not properly fixed
- Hemolyzed or contaminated specimen
- Incorrect labeling
Understanding Your Results
Actionable mutation (e.g., EGFR, ALK, BRAF)
May indicate eligibility for targeted therapy.
High Tumor Mutation Burden (TMB-H)
May predict response to immune checkpoint inhibitors.
Microsatellite Instability (MSI-H)
May respond to PD-1 inhibitors.
No pathogenic mutations detected
No targetable alterations found; standard chemotherapy may be considered.
If you experience any cancer-related symptoms such as unexplained weight loss, persistent fatigue, or unusual bleeding, consult your doctor immediately. Early detection and genetic profiling can significantly improve treatment outcomes.
Limitations
- ⚠This test detects somatic mutations in tumor tissue; it does not assess germline mutations unless specifically requested.
- ⚠The panel may not detect all possible genetic alterations, such as large structural rearrangements or epigenetic changes.
- ⚠Results should be interpreted in the context of clinical and pathological findings.
- ⚠The test is not intended for screening healthy individuals.
Risks & Considerations
- ●Bleeding or infection at biopsy site
- ●Pain or discomfort
- ●Rare risk of damage to surrounding tissues
Interfering Factors
- ●Insufficient tumor content in the sample
- ●Poor DNA quality due to prolonged formalin fixation
- ●Decalcification of bone specimens
- ●Necrotic tissue
- ●Contamination with normal tissue
Compare With Similar Tests
| Test | Comprehensive Tumor Panel 320 Genes | Comprehensive Tumor Panel 320 Genes | Targeted Cancer Panel (50 Genes) | Hereditary Cancer Panel (84 Genes) |
|---|---|---|---|---|
| Comparison | Comprehensive Tumor Panel 320 Genes |
Frequently Asked Questions
What is the cost of the Comprehensive Tumor Panel 320 Genes test?
What sample is required for this test?
How long does it take to get results?
Is fasting required before the test?
Can this test detect all types of cancer?
Is home sample collection available?
What is the method used for testing?
Will this test help in choosing targeted therapy?
Is this test covered by insurance?
What is the sample stability?
Are there any risks associated with the biopsy?
Can this test be done on blood sample?
Related Tests
B-Cell Rearrangement Detection Test
₹22,000Acute Lymphoblastic Leukemia (ALL) Cytogenetics Panel Test
₹20,000Epstein-Barr Virus Early RNA (EBER-ISH) In-Situ-Hybridization Test
₹6,000OncoPro NCCN Lung Cancer Panel with PD-L1 Test
₹140,400Acute Myeloid Leukemia (AML) Cytogenetics Panel Test
₹23,000AML ETO t(8;21) Gene Rearrangement PCR Qualitative Test
₹6,000Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.